How precision medicine will transform clinical trials

<p><span data-contrast="auto">In the</span><a href= "https://www.ddw-online.com/t/in-conversation-series/"><em><span data-contrast="auto"> In Conversation With</span></em> </a><span data-contrast= "auto">series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. </span> <span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p> <p><span data-contrast="auto">In this latest episode, DDW's Megan Thomas is</span> in conversation with <span class= "SpellingError SCXW120345688 BCX0">Dr</span><span class= "NormalTextRun SCXW120345688 BCX0"> Michael Pace, Global & Strategic Feasibility Expert at Rho. </span></p> <div class="OutlineElement Ltr SCXW51669256 BCX0"> <p class="Paragraph SCXW51669256 BCX0"><span class= "TextRun SCXW51669256 BCX0" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class= "NormalTextRun SCXW51669256 BCX0">Leveraging historical trial databases has become commonplace in assessing the feasibility of trials in therapeutic areas with a large breadth of clinical development history. In the future, clinical trials are going to come down to the patient level, similar to how therapies are moving toward personalisation based on biomarkers, genetics and more. EHR data also has a key role to play in designing future clinical trials.</span></span> <span class="EOP SCXW51669256 BCX0" data-ccp-props="{}">In this episode,</span> <span class= "TextRun SCXW51669256 BCX0" lang="EN-GB" xml:lang="EN-GB" data-contrast="auto"><span class= "NormalTextRun SCXW51669256 BCX0">Dr Pace discusses how precision medicine is already starting to influence standards in clinical trial design.</span></span> <span class="EOP SCXW51669256 BCX0" data-ccp-props="{}"> </span></p> </div>